Histology and Cytology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Cytology Market Trends and the Market is Segmented by Type of Examination (Histology and Cytology), Test Type (Microscopy Tests, Molecular Genetics Tests and Flow Cytometry), End-User (Hospitals and Clinics, Academic and Research Institutes. and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Provides the Value (in USD Million) for the Above-Mentioned Segments.

Histology and Cytology Market Size

Single User License
Team License
Corporate License
Book before:
Histology and Cytology Market Summary
share button
Study Period 2019 - 2029
Market Size (2024) USD 20.54 Billion
Market Size (2029) USD 38.70 Billion
CAGR (2024 - 2029) 13.50 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Histology and Cytology Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Histology and Cytology Market Analysis

The Histology and Cytology Market size is estimated at USD 20.54 billion in 2024, and is expected to reach USD 38.70 billion by 2029, growing at a CAGR of 13.5% during the forecast period (2024-2029).

COVID-19 had a significant impact on the growth of the market. This is mainly due to the development of new cytology and histology tests during the pandemic. For instance, an article published by Frontiers in January 2022 stated a new method for the sputum cytology test without direct contact with specimens during the COVID-19 pandemic. Moreover, in an article published by PubMed Central in February 2021, a study was conducted in India, which showed a 92.6% reduction in cytology samples received during the pandemic. Thus, the development of such new cytology methods and the reduction in cytology tests had a significant impact on the market during the pandemic period. However, as the pandemic has subsided, the studied market is expected to have normal growth during the forecast period of the study.

The propelling factors for the growth of the histology and cytology market include the rising prevalence of cancer, increasing standardization of pathological laboratories, and technological advancements in diagnostic and molecular techniques,

The increasing prevalence of cancer is a major factor driving the market growth as histology and cytology tests are majorly used to diagnose cancer. For instance, according to the data published by the Spanish Network of Cancer Registries in January 2021, an estimated 276.2 thousand new cases of cancer were diagnosed in Spain in the previous year out of which 43.6 thousand were colorectal cancer cases, 35.8 thousand were prostate cancer cases, and 33.4 thousand breast cancer cases were diagnosed.

Moreover, according to an article published by the Indian Journal of Medical Research in November 2022, it was estimated that in India, the incidence of cancer cases would likely increase from 1.46 million in the previous year to 1.57 million in two years. The national average for the year 2022 of the crude rate of incidence per 100,000 was 100.4 for males and 95.6 for females. Thus, the increasing prevalence of cancer worldwide is a major factor driving the market growth.

Furthermore, the developments such as product launches by various organizations and market players are also expected to boost the market growth, leading to a higher adoption of histology and cytology products. For instance, in June 2022, the Fine Needle Aspiration Cytology (FNAC) test facility has been launched at the Almora Medical College. This test helps in the detection of chronic diseases like cancer, at an early stage.

Thus, the above mentioned factors such as the rising prevalence of cancer and the increasing developments such as product launches by various organizations and market players are expected to drive the growth of the studied market during the forecast period. However, safety issues and diagnostic accuracy issues with histopathological and cytopathological tests and the lack of awareness among the public for diagnostic tests are expected to hinder the market growth.

Histology and Cytology Market Trends

Cervical Cancer Segment is Expected to Have a Significant Market Share During the Forecast Period

Cytology tests are useful for both the diagnosis and screening of cervical cancer. The cytology segment has a wide range of applications in cervical cancer types. As companies focus more on molecular diagnosis, cytology is expected to play a vital role in the diagnosis of cervical cancer.

The rising prevalence of cervical cancer is a major factor driving the market growth. For instance, according to the data updated by Cancer Australia in August 2022, an estimated 942 new cases of cervical cancer were diagnosed in Australia in the current year, which will account for 1.3% of the latest female cancer cases diagnosed in the country. Thus, the country's high prevalence of cervical cancer is expected to boost segment growth.

Moreover, according to the data updated by ICO/IARC Information Centre on HPV and Cancer in March 2023, an estimated 4,666 cervical cancer cases are diagnosed in Germany every year, and about 3.2% of women in the general population of Germany are estimated to harbour cervical human papillomavirus (HPV)-16/18 infection at a given time, and 76.5% of invasive cervical cancers are attributed to HPVs 16 or 18. Thus, the country's high prevalence of HPV-related cervical cancers is also expected to enhance segment growth.

Moreover, the rising cervical cancer screening initiatives are also expected to enhance segment growth. For instance, in December 2021, BC Cancer launched an at-home cervix screening pilot in Central Vancouver Island and the Sunshine Coast in Canada, improving access to screening and helping to prevent cervical cancer.

Thus, owing to the above factors, such as the rising prevalence of cervical cancer, the demand for cervical cancer cytological methods is expected to increase.

Histology and Cytology Market - Estimated Number of New Cervical Cancer Cases (in thousands), United States, 2022-2023

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

North America is expected to hold a significant market share in the histology and cytology market due to the increasing geriatric population, growing cancer incidence, and rising awareness about cancer screening in this region. For instance, according to the American Cancer Society's report in 2023, over 1.96 million new cancer cases are expected to be diagnosed in the United States in the current year. Additionally, 80% of the people diagnosed with cancer in the United States are 55 or older, and 57% are 65 or older. Thus, due to the high prevalence of cancer and the rising affected geriatric population, the demand for diagnostics contributes to the market's growth.

Moreover, according to the January 2022 update by breastcancer.org, around 1 in 8 women in the country (about 13%) develop invasive breast cancer over their lifetime. The same source reports that, in 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, as well as 51,400 new cases of non-invasive (in situ) breast cancer. As per the same source, about 2,710 new cases of invasive breast cancer are expected to be diagnosed in men in 2022. A man's lifetime risk of breast cancer is about 1 in 833. Hence, all these factors are expected to help propel the histology and cytology market.

Product approvals in the United States are also expected to contribute to the market's growth. For instance, in May 2021, Hologic received the United States Food and Drug Administration's premarket approval of the Company's ThinPrep Genesis processor for cytology processing and specimen transfer for downstream applications.

Furthermore, awareness about advanced therapeutics and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Histology and Cytology Market - Growth Rate by Region

Histology and Cytology Industry Overview

The histology and cytology market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the key players operating are Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Hologic Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., and Trivitron Healthcare.

Histology and Cytology Market Leaders

  1. Abbott Laboratories

  2. Becton Dickinson and Company

  3. Merck KGaA

  4. F. Hoffmann-La Roche Ltd

  5. Hologic Inc

*Disclaimer: Major Players sorted in no particular order

Histology and Cytology Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Histology and Cytology Market News

  • February 2023: BioReference Health LLC announced today it would be one of the first commercial laboratories to offer the CINtec PLUS Cytology test from Roche Diagnostics. CINtec PLUS Cytology is the only FDA-approved dual-stain triage test for patients who have a positive high-risk human papillomavirus (HPV) result.
  • July 2022: Nanostics Inc. launched a prospective clinical study to validate a novel and minimally invasive bladder cancer diagnostic test, Clarity DX Bladder, using its Clarity DX diagnostic platform.

Histology and Cytology Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Cancer

      2. 4.2.2 Increasing Standardization of Pathological Laboratories

      3. 4.2.3 Technological Advancements in Diagnostic and Molecular Techniques

    3. 4.3 Market Restraints

      1. 4.3.1 Safety Issues and Diagnostic Accuracy Issues with Histopathological and Cytopathological Tests

      2. 4.3.2 Lack of Awareness among the Public for Diagnostic Tests

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 5.1 By Type of Examination

      1. 5.1.1 Histology

      2. 5.1.2 Cytology

        1. 5.1.2.1 Breast Cancer

        2. 5.1.2.2 Cervical Cancer

        3. 5.1.2.3 Others

    2. 5.2 By Test Type

      1. 5.2.1 Microscopy Tests

        1. 5.2.1.1 Cytogenic Tests

          1. 5.2.1.1.1 Karyotyping

          2. 5.2.1.1.2 Fluorescent In-situ Hybridization (FISH)

        2. 5.2.1.2 Polymerase Chain Reaction

        3. 5.2.1.3 Other Microscopy Tests

      2. 5.2.2 Molecular Genetics Tests

      3. 5.2.3 Flow Cytomtery

    3. 5.3 By End User

      1. 5.3.1 Hospitals and Clinics

      2. 5.3.2 Academic and Research Institutes

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott

      2. 6.1.2 Becton Dickinson and Company

      3. 6.1.3 Danaher Corporation

      4. 6.1.4 F. Hoffmann-La Roche Ltd

      5. 6.1.5 Hologic Inc.

      6. 6.1.6 Merck KGaA

      7. 6.1.7 PerkinElmer Inc.

      8. 6.1.8 Sysmex Corporation

      9. 6.1.9 Thermo Fisher Scientific Inc.

      10. 6.1.10 Trivitron Healthcare

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Histology and Cytology Industry Segmentation

As per the scope of the report, cytology and histology are two different branches of pathology, where cytology mainly involves looking at individual cells or clusters of cells, and histology involves examining an entire section of tissue containing many types of cells. 

The Histology and Cytology Market is Segmented by Type of Examination (Histology and Cytology), Test Type (Microscopy Tests, Molecular Genetics Tests and Flow Cytometry), End-User (Hospitals and Clinics, Academic and Research Institutes. and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Type of Examination
Histology
Cytology
Breast Cancer
Cervical Cancer
Others
By Test Type
Microscopy Tests
Cytogenic Tests
Karyotyping
Fluorescent In-situ Hybridization (FISH)
Polymerase Chain Reaction
Other Microscopy Tests
Molecular Genetics Tests
Flow Cytomtery
By End User
Hospitals and Clinics
Academic and Research Institutes
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Histology and Cytology Market Research FAQs

The Histology and Cytology Market size is expected to reach USD 20.54 billion in 2024 and grow at a CAGR of 13.5% to reach USD 38.70 billion by 2029.

In 2024, the Histology and Cytology Market size is expected to reach USD 20.54 billion.

Abbott Laboratories, Becton Dickinson and Company, Merck KGaA, F. Hoffmann-La Roche Ltd and Hologic Inc are the major companies operating in the Histology and Cytology Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Histology and Cytology Market.

In 2023, the Histology and Cytology Market size was estimated at USD 17.77 billion. The report covers the Histology and Cytology Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Histology and Cytology Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

The major challenges in the Histology and Cytology Market are a) Increasing pressure to reduce healthcare spending can limit investment in laboratory infrastructure and advanced technologies b) Implementing and maintaining rigorous quality control measures requires ongoing effort and resources

Histology and Cytology Industry Report

The global histology and cytology market is on an upswing, fueled by the growing incidence of cell-based diseases, such as cancer, and heightened demand for accurate tissue and cell analysis. Digital cytology systems and the application of immunohistochemistry are revolutionizing diagnosis, making way for effective disease detection and management. With the cytology segment taking the lead, particularly for breast and cervical cancer through cost-effective screening methods like FNAC and Pap smear, there's a noticeable impact on mortality rates. The market also benefits from advancements in consumables, reagents, and software systems, essential for the routine adoption and innovation in this field. The drug discovery segment, powered by histomorphometry and IHC staining, alongside North America's robust R&D landscape and Asia Pacific's surging growth due to increased cancer awareness, signals a promising future driven by digital innovations and early detection strategies. Mordor Intelligence™ provides detailed market insights, highlighting this sector's expansion and future prospects. Statistics for the Histology and Cytology market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Histology and Cytology analysis includes a market forecast outlook and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Histology and Cytology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)